Israeli multimodality vendor Elscint received Food and Drug Administration510(k) clearance last month for SeleCT/SP, an entry-level spiralCT scanner designed for cost-conscious customers (SCAN 7/17/96).The compact scanner, which was introduced at last
Israeli multimodality vendor Elscint received Food and Drug Administration510(k) clearance last month for SeleCT/SP, an entry-level spiralCT scanner designed for cost-conscious customers (SCAN 7/17/96).The compact scanner, which was introduced at last year's RadiologicalSociety of North America meeting, uses a unique short-geometrydesign to save space. Elscint plans to begin international deliveriesof SeleCT/SP in the third quarter, with U.S. shipments startingin the fourth quarter.
In other SeleCT/SP news, Elscint signed an agreement with BirlaMedical Technologies of India in which BMT will assemble SeleCT/SPunder license for sale in the Indian market. BMT expects to beginassembling SeleCT/SP scanners in a factory near New Delhi laterthis year.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.